⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15944871 | 1.00 | — | — | |
| SCHEMBL649682 | 0.83 | ALDH1A1 (0.37) | — | |
| SCHEMBL755085 | 0.79 | TAAR1 (0.59) | — | |
| SCHEMBL7545271 | 0.77 | TAAR1 (0.56) | — | |
| SCHEMBL12437153 | 0.75 | HRH3 (0.31) | — | |
| SCHEMBL23461 | 0.75 | — | — | |
| SCHEMBL16561361 | 0.73 | IDO1 (0.58) | — | |
| SCHEMBL7437052 | 0.73 | TAAR1 (0.68) | — | |
| SCHEMBL1468357 | 0.73 | IDO1 (0.58) | — | |
| SCHEMBL679947 | 0.73 | HRH3 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117820731-A | Material composition, perovskite layer, solar cell and photovoltaic module | 通威太阳能（成都）有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-111269205-B | Preparation method of C-aryl glycoside compound | 华侨大学 | 2023-05-26 | — | — | CN | claimed |
| CN-115611714-B | Star-shaped ether compound, electrolyte and lithium battery | 比亚迪股份有限公司 | 2025-03-21 | — | — | CN | disclosed |
| WO-2024108090-A1 | METHODS OF TREATING INFLAMMATORY CONDITIONS | ATHIRA PHARMA, INC. (US) | 2024-05-23 | — | — | WO | disclosed |
| WO-2024091882-A1 | SMALL MOLECULE DIRECT INHIBITORS OF KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2024-05-02 | — | — | WO | disclosed |
| WO-2023215377-A1 | METHODS OF TREATING NEUROINFLAMMATORY CONDITIONS | ATHIRA PHARMA, INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| WO-2023215376-A1 | METHODS OF TREATING NEUROPATHIES | ATHIRA PHARMA, INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| WO-2023215378-A1 | METHODS OF TREATING FIBROSIS | ATHIRA PHARMA, INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| WO-2023163971-A1 | METHODS OF TREATING COVID-RELATED DISORDERS | ATHIRA PHARMA, INC. (US) | 2023-08-31 | — | — | WO | disclosed |
| EP-4219499-A1 | A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (CN) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023114456-A1 | USES OF BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASES | ATHIRA PHARMA, INC. (US) | 2023-06-22 | — | — | WO | disclosed |
| WO-1995012589-A1 | PROCESS FOR THE PREPARATION OF N-4-[(SUBSTITUTED PHENYL)ALKYLTHIENYL]-, AND N-4-[(SUBSTITUTED PHENYL)ALKYLFURYL]BUT-3-YN-2-YL]-N-HYDROXYUREA COMPOUNDS | ABBOTT LABORATORIES (US) | 1995-05-11 | — | — | WO | disclosed |
| EP-0619814-A1 | OXADIAZOLE DERIVATIVES HAVING ACETYLCHOLINESTERASE-INHIBITORY AND MUSCARINIC AGONIST ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-10-19 | — | — | EP | disclosed |
| WO-1994011342-A1 | SUBSTITUTED ARYLALKYNYL- AND HETEROARYLALKYNYL-N-HYDROXYUREA INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS | ABBOTT LABORATORIES (US) | 1994-05-26 | — | — | WO | disclosed |
| EP-0562849-A2 | Steroid derivatives | ELI LILLY AND COMPANY (US) | 1993-09-29 | — | — | EP | disclosed |
| WO-1993013083-A1 | OXADIAZOLE DERIVATIVES HAVING ACETYLCHOLINESTERASE-INHIBITORY AND MUSCARINIC AGONIST ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-08 | — | — | WO | disclosed |
| US-4552895-A | ANTIARTHRITIC, ANTITUMOR, PSORIASIS | ELI LILLY AND COMPANY (US) | 1985-11-12 | — | — | US | disclosed |
| EP-0119795-A1 | Angiogenesis factor inhibitors | ELI LILLY AND COMPANY (US) | 1984-09-26 | — | — | EP | disclosed |
| US-4017631-A | MICROBIOCIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1977-04-12 | — | — | US | disclosed |
| US-3991202-A | ANTIMICROBIALS | JANSSEN PHARMACEUTICA N.V. (BE) | 1976-11-09 | — | — | US | disclosed |